Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Reactions Weekly

Issue 1/2008

Content (86 Articles)

News item

Antidepressant use too rare to impact population suicide rates?

Clinical study

Inconclusive findings for aprotinin in paediatric renal impairment

Clinical study

The perception that gemfibrozil has a less favourable safety profile than fenofibrate may no longer be clinically relevant

Clinical study

A 6-hour oxaliplatin infusion is associated with prevention and reduction of acute neurotoxicity

Media release

Neurological adverse effects associated with bevacizumab [Avastin] may arise from damage to brain blood vessels

Meeting report

News from GCS

Clinical study

HAART initiation at CD4 cell counts of ≥ 200 cells/mm3 is associated with a decreased risk of anaemia, renal impairment and peripheral neuropathy

Media release

An interim analysis of ADVANCE* data provides “no confirmation” of the adverse mortality trend** seen in the ACCORD* trial

News item

Hep B vax not linked to childhood-onset MS

Clinical study

Corticosteroid administration in the acute phase of cerebral venous thrombosis (CVT) does not improve outcomes

Clinical study

Efavirenz has a clinically significant effect on voriconazole pharmacokinetics

Clinical study

Concomitant CYP3A4 inhibitors and calcium channel antagonist therapy is associated with an increased risk of adverse drug reactions

Clinical study

Concomitant SSRI and NSAID treatment appears to have a synergistic effect on the risk of upper GI bleeding

Media release

Serious adverse reactions have been reported with ephedrine-containing slimming drugs, Therma Power and Grenade Fat Burner

Media release

Risk of peripheral neuropathy to be added to telbivudine label

Media release

Transdermal fentanyl patches are being recalled voluntarily by the manufacturer

Media release

The UK MHRA is launching a 6-week campaign to get pharmacists to mention the Yellow Card scheme to customers

Case report

Abciximab

Case report

Adalimumab/infliximab

Case report

Adenosine

Case report

Antineoplastics/cidofovir

Case report

Atracurium besilate interaction

Case report

Alfentanil/propofol

Case report

Atracurium besilate/pethidine/thiopental sodium

Case report

Benznidazole

Case report

Azathioprine

Case report

Bevacizumab

Case report

Bevacizumab

Case report

Bevacizumab/oxaliplatin/S-1

Case report

Bevacizumab

Case report

Carbamazepine/chloral hydrate

Case report

Bimatoprost/latanoprost

Case report

Ciclosporin/mycophenolate mofetil/prednisolone

Case report

Desipramine/venlafaxine

Case report

Efavirenz/lamivudine/tenofovir

Case report

DTaP poliovirus vaccine/measles mumps and rubella virus vaccine

Case report

Efalizumab

Case report

Epinephrine

Case report

Eptacog alfa

Case report

Everolimus

Case report

Fingolimod

Case report

Etanercept

Case report

Gatifloxacin

Case report

Fluorescein

Case report

Gemtuzumab ozogamicin

Case report

Griseofulvin

Case report

Herbal medicines

Case report

Granulocyte colony-stimulating factors

Case report

Hydroxychloroquine

Case report

Infliximab

Case report

Imatinib

Case report

Imatinib

Case report

Infliximab

Case report

Loxoprofen

Case report

Iodine 131

Case report

Insulin aspart/insulin glargine

Case report

Meropenem interaction

Case report

Methadone overdose

Case report

Metronidazole

Case report

Mycophenolate mofetil

Case report

Mycophenolate mofetil

Case report

Mometasone

Case report

Neomycin

Case report

Olmesartan medoxomil

Case report

Pegfilgrastim

Case report

Olanzapine

Case report

Piroxicam

Case report

Peginterferon-α-2a/ribavirin

Case report

Pramipexole

Case report

Rifabutin

Case report

Rituximab

Case report

Ritonavir/tipranavir

Case report

Sulfasalazine

Case report

Sulfasalazine

Case report

Rocuronium bromide

Case report

Tamoxifen

Case report

Tacrolimus interaction

Case report

Tacrolimus/metformin

Case report

Thalidomide

Case report

Triamcinolone

Case report

Valproic acid overdose

Case report

Topiramate

Case report

Zoledronic acid

Case report

Voriconazole

Case report

Voriconazole

Case report

Zoledronic acid

Feb 08
Issue: 1/2008
Mar 08
Issue: 1/2008

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more